Skip to main content
Premium Trial:

Request an Annual Quote

Structural Bioinformatics, ChemNavigator Enter Drug-Discovery Pact

NEW YORK, Sept. 5 – Structural Bioinformatics and ChemNavigator have agreed to combine their technologies in order to identify novel drug candidates, SBI announced on Wednesday.

According to the terms of the agreement, SBI and its customers will have access to ChemNavigator’s iResearch System, a database of chemical structures for 2 million drug-like compounds. This information can then be screened against SBI’s own drug-target database of three-dimensional protein structures.

Although financial details were not disclosed, the companies said in a statement that they would share any revenues generated from the combined use of their technologies.

“Screening our compound library against [SBI’s] active sites will result in the quick identification of drug candidates that can be moved into lead optimization programs in months rather than years,” ChemNavigator CEO Scott Hutton said in the statement.

The companies, both based in San Diego, said they initially plan to apply their joint technologies to investigating clinical targets for certain cancers and diabetes.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.